Evidence map›Paper›PMID 40890299›Full record

ArticleBritish journal of cancer2025

Correction: RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer.

Derek Dustin, Guowei Gu, Amanda R Beyer, Sarah K Herzog, David G Edwards, Hangqing Lin, Thomas L Gonzalez, Sandra L Grimm, Cristian Coarfa, Doug W Chan and 7 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Derek DustinLester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA.
Guowei GuLester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA.
Amanda R BeyerLester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA.
Sarah K HerzogLester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA.
David G EdwardsLester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA.
Hangqing LinLester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA.
Thomas L GonzalezLester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA.
Sandra L GrimmDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.
Cristian CoarfaDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.
Doug W ChanLester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA.
Beom-Jun KimLester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA.
Jean-Paul De La OUniversity of Utah Huntsman Cancer Institute, Salt Lake City, Utah, USA.
Matthew J EllisLester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA.
Dan LiuDepartment of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX, USA.
Shunqiang LiWashington University School of Medicine, St. Louis, MO, USA.
Alana L WelmUniversity of Utah Huntsman Cancer Institute, Salt Lake City, Utah, USA.ORCID http://orcid.org/0000-0002-1412-1351
Suzanne A W FuquaLester & Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA. sfuqua@bcm.edu.ORCID http://orcid.org/0000-0001-8886-5161

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40890299
PMCPMC12449453

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.